Teijin from Japan fuels U.S. medtech startup!

Japanese chemical company Teijin has invested in Garwood Medical Devices, a US startup developing a device for treating infections after prosthetic joint implant surgery. Garwood’s device, BioPrax, is designed to combat bacterial infections on implants. Teijin aims to cooperate with Garwood in research and commercialization efforts.